Robert Goldin
0000-0001-5184-4519
Publication & Citation Trends
Publications
0 total
Characterization of T cell subsets and dynamic remodeling following immune checkpoint inhibition in hepatocellular carcinoma
Cited by 0
Semantic Scholar
Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.
Cited by 0
Semantic Scholar
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Cited by 0
Semantic Scholar
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis OA
Cited by 44
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(163)
Hepatitis C virus research
(113)
Hepatocellular Carcinoma Treatment and Prognosis
(112)
Cancer Immunotherapy and Biomarkers
(84)
Renal cell carcinoma treatment
(67)
Affiliations
University of London
SIB Swiss Institute of Bioinformatics
Brigham and Women's Hospital
The Honourable Society of Lincoln's Inn
Royal Marsden NHS Foundation Trust